{"id":3757,"date":"2019-09-06T19:24:43","date_gmt":"2019-09-06T23:24:43","guid":{"rendered":"https:\/\/www.medteq.ca\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/"},"modified":"2019-09-06T19:24:43","modified_gmt":"2019-09-06T23:24:43","slug":"2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies","status":"publish","type":"post","link":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/","title":{"rendered":"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies"},"content":{"rendered":"

Montreal, September 5, 2019<\/strong>\u00a0\u2014\u00a0 MIMS is proud to announce the closing of a $ 2.6 million seed round with the participation of Anges Qu\u00e9bec, Anges Qu\u00e9bec Capital, Consortium MEDTEQ, Desjardins Capital, Real Ventures and StandUp Ventures. With this funding, MIMS intends to develop so-called turnkey and integrated solutions enabling life scientists, without expertise in bioinformatics or data sciences, to stratify human, animal and plant populations.<\/p>\n

The company, based in Montreal, offers a SAAS platform for analyzing omics data, by using different types of artificial intelligence, in order to facilitate the use by non-computer scientists of bioinformatics and very complex data science methodologies to generate predictive models for companies from the biopharmaceutical and agtech sectors.<\/p>\n

\u201cMIMS sets itself apart from other AI startups, because of our ability to leverage what we call \u2018fat data\u2019 using AI, which is very difficult to do. These data are of great strategic value for companies in the biopharmaceutical agricultural technology sectors\u201d explains Sarah Jenna, co-founder and CEO of MIMS.<\/p>\n

\u201cThe particularity of MIMS lies in its innovation in artificial intelligence within the health sector. We are convinced that the forward-thinking nature of this company is the key their success. MIMS will contribute to life sciences companies that are ready to welcome the artificial intelligence era. We are witnessing a significant change\u201d says Jean-Marc Rousseau, angel investor at Anges Qu\u00e9bec.<\/p>\n

\u201cWe are pleased to support MIMS through this direct investment, but also through grants, because of the scalable potential of their platform and their ability to execute.\u00a0 Under the leadership of Sarah Jenna and through collaborative projects of research, the MIMS team has been successful in generating and leveraging an impressive amount of data, and we see a bright future for MIMS\u201d,\u00a0 said Robert Ritlop, Investment Director at MEDTEQ.<\/p><\/blockquote>\n

Real Ventures, through its Orbite investment strategy in the pre-seed and seed stage, is also proud to continue to support MIMS following its participation in the FounderFuel acceleration program in 2017.<\/p>\n

\u201cIt is still too rare in Quebec to see university professors, with the specialized expertise of their field, go from academia to entrepreneurship.\u00a0 It was a great pleasure to see the shock of ideas and the challenge to deliver, the theoretical expertise and the practical implementation, the evolution of the leadership under the guidance of Sarah Jenna and her co-founders.\u00a0 This is for us the validation of our thesis of investment in scientists, engineers and hackers, it\u2019s just a milestone in the course, but it\u2019s very promising\u201d says Sylvain Carle, Partner at Real Ventures and Chief Mentor at FounderFuel, who worked closely with MIMS in the early days.<\/p><\/blockquote>\n

Collaboration with two flagship projects<\/strong><\/p>\n

MIMS is currently collaborating on two flagship projects to demonstrate the full potential of its solution in the field of health and agtech. The first is a triple-negative breast cancer clinical trial, in collaboration with the Jewish General Hospital, which aims to identify groups of patients most receptive to chemotherapy treatment.<\/p>\n

The second is a collaboration with a dairy consortium, also involving research laboratories and the Valacta Center of Expertise in Milk Production, to stratify cow populations in order to develop more efficient recommendation systems for farmers, enabling them to thus to increase their profitability.<\/p>\n

\n

About MIMS<\/strong><\/em><\/p>\n

My Intelligences Machines (MIMS) is a company that was founded in 2016 by Sarah Jenna, Micka\u00ebl Camus and Abdoulaye Banir\u00e9 Diallo in order to enable the life science industries to develop a more effective and personalized medicine and agriculture by helping companies leverage the fat data they generate.<\/em><\/p>\n

About Anges Qu\u00e9bec<\/strong><\/em><\/p>\n

In operation since 2009, Anges Qu\u00e9bec is a network of more than 230 angel investors who invest time and capital in innovative Quebec companies with high growth potential. The members of the Anges Qu\u00e9bec network have, to date, invested more than $80 million in the Qu\u00e9bec economy, with more than 210 investments in more than 115 innovative companies. Thanks to its professional development center, Anges Qu\u00e9bec supports its members in the constant acquisition of new knowledge and skills inherent in the investment.<\/em><\/p>\n

About Anges Qu\u00e9bec Capital<\/strong><\/em><\/p>\n

Founded in 2012, Anges Qu\u00e9bec Capital is an $86 million investment fund, sponsored by Investissement Qu\u00e9bec, through its own funds and as agent of the Government of Quebec, the Caisse de d\u00e9p\u00f4t et placement du Qu\u00e9bec (CDPQ), the Fonds de solidarit\u00e9 FTQ and members of Anges Qu\u00e9bec. Its mission is to accompany the 230 members of Anges Qu\u00e9bec in their investments. \u00a0The joint effort of angels and sponsors results in more than $86 million made available to innovative Quebec entrepreneurs, allowing them to benefit from substantial financial leverage to significantly increase their business development.\u00a0 As of now, Anges Qu\u00e9bec Capital has invested over $44 million in 48 innovative companies, for a total of 100 transactions.\u00a0\u00a0www.angesquebeccapital.com<\/a><\/em><\/p>\n

About Consortium MEDTEQ<\/strong><\/em><\/p>\n

MEDTEQ is the pan-Canadian Consortium for Industrial Research and Innovation in Medical Technology. Its mission is to accelerate the development of innovative technological solutions to improve patients\u2019 health and quality of life. MEDTEQ supports their validation and integration in the healthcare system and their impact, both locally and globally, by bringing together the complementary skills of industrial and academic partners, and with those of healthcare providers. MEDTEQ relies on the financial support of the Government of Quebec, the Government of Canada (delivered through the\u00a0Centres of Excellence for Commercialization and Research<\/a>\u00a0(CECR)), the private sector and complementary partners to foster research-industry relations.\u00a0\u00a0www.medteq.ca<\/a><\/em><\/p>\n

About Desjardins Capital<\/strong><\/em><\/p>\n

With nearly 45 years of expertise,\u00a0Desjardins Capital<\/a>\u00a0has the mission of valuing, supporting and retaining SMEs in Quebec. With $ 2.4 billion in assets under management, Desjardins Capital contributes to the sustainability of nearly 470 companies, cooperatives and funds operating in various sectors of activity and from all regions of Qu\u00e9bec. In addition to helping to maintain and create some 58,000 jobs, this\u00a0Mouvement Desjardins<\/a>\u00a0component provides entrepreneurs with access to a broad business network to support the growth of their businesses. For more information, visit our\u00a0website<\/a>\u00a0or visit our\u00a0LinkedIn<\/a>\u00a0page.<\/em><\/p>\n

About StandUp Ventures<\/strong><\/em><\/p>\n

StandUp Ventures invests in breakthrough companies led or co-led by women. We believe that women-led companies think outside the box, recruit great talent, and serve bigger markets. We invest in Canadian pre-seed and seed-stage technology companies with at least one woman in a C-level leadership position within the company. \u00a0For more information, please visit\u00a0www.standupvc.com<\/a><\/em><\/p>\n

 <\/p>\n

SOURCE :<\/strong><\/p>\n

Anges Qu\u00e9bec<\/p>\n

MIMS<\/p>\n

 <\/p>\n

Media Inquiries\u00a0:<\/strong><\/p>\n

Simon Boiteau<\/p>\n

TACT Intelligence-conseil<\/p>\n

Mobile: 514-506-5840<\/p>\n

sboiteau@tactconseil.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Montreal, September 5, 2019\u00a0\u2014\u00a0 MIMS is proud to announce the closing of a $ 2.6 million seed round with the participation of Anges Qu\u00e9bec, Anges Qu\u00e9bec Capital, Consortium MEDTEQ, Desjardins Capital, Real Ventures and StandUp Ventures. With this funding, MIMS intends to develop so-called turnkey and integrated solutions enabling life scientists, without expertise in bioinformatics […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-3757","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\n$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies | MEDTEQ+<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies | MEDTEQ+\" \/>\n<meta property=\"og:description\" content=\"Montreal, September 5, 2019\u00a0\u2014\u00a0 MIMS is proud to announce the closing of a $ 2.6 million seed round with the participation of Anges Qu\u00e9bec, Anges Qu\u00e9bec Capital, Consortium MEDTEQ, Desjardins Capital, Real Ventures and StandUp Ventures. With this funding, MIMS intends to develop so-called turnkey and integrated solutions enabling life scientists, without expertise in bioinformatics […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"MEDTEQ+\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-06T23:24:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.medteq.ca\/wp-content\/uploads\/2024\/12\/screenshot.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"880\" \/>\n\t<meta property=\"og:image:height\" content=\"660\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"boreale_user\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@medteq_ca\" \/>\n<meta name=\"twitter:site\" content=\"@medteq_ca\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"boreale_user\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\\\/\"},\"headline\":\"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies\",\"datePublished\":\"2019-09-06T23:24:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\\\/\"},\"wordCount\":1090,\"publisher\":{\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\\\/\",\"url\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\\\/\",\"name\":\"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies | MEDTEQ+\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/#website\"},\"datePublished\":\"2019-09-06T23:24:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.medteq.ca\\\/en\\\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/\",\"name\":\"MEDTEQ+\",\"description\":\"Innovation for health\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/#organization\"},\"alternateName\":\"MEDTEQ+\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/#organization\",\"name\":\"MEDTEQ+\",\"url\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.medteq.ca\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/medteq-new-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.medteq.ca\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/medteq-new-logo.png\",\"width\":505,\"height\":70,\"caption\":\"MEDTEQ+\"},\"image\":{\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/medteq_ca\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/medteq-plus\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/#\\\/schema\\\/person\\\/deecfd9589f1fadb79527a1f888d8cc5\",\"name\":\"boreale_user\",\"url\":\"https:\\\/\\\/www.medteq.ca\\\/en\\\/author\\\/boreale\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies | MEDTEQ+","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/","og_locale":"en_US","og_type":"article","og_title":"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies | MEDTEQ+","og_description":"Montreal, September 5, 2019\u00a0\u2014\u00a0 MIMS is proud to announce the closing of a $ 2.6 million seed round with the participation of Anges Qu\u00e9bec, Anges Qu\u00e9bec Capital, Consortium MEDTEQ, Desjardins Capital, Real Ventures and StandUp Ventures. With this funding, MIMS intends to develop so-called turnkey and integrated solutions enabling life scientists, without expertise in bioinformatics […]","og_url":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/","og_site_name":"MEDTEQ+","article_published_time":"2019-09-06T23:24:43+00:00","og_image":[{"width":880,"height":660,"url":"https:\/\/www.medteq.ca\/wp-content\/uploads\/2024\/12\/screenshot.jpg","type":"image\/jpeg"}],"author":"boreale_user","twitter_card":"summary_large_image","twitter_creator":"@medteq_ca","twitter_site":"@medteq_ca","twitter_misc":{"Written by":"boreale_user","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/#article","isPartOf":{"@id":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/"},"headline":"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies","datePublished":"2019-09-06T23:24:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/"},"wordCount":1090,"publisher":{"@id":"https:\/\/www.medteq.ca\/en\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/","url":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/","name":"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies | MEDTEQ+","isPartOf":{"@id":"https:\/\/www.medteq.ca\/en\/#website"},"datePublished":"2019-09-06T23:24:43+00:00","breadcrumb":{"@id":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.medteq.ca\/en\/2-6m-seed-round-for-mims-the-startup-that-uses-ai-to-optimize-the-productivity-of-biopharmaceutical-and-agtech-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.medteq.ca\/en\/"},{"@type":"ListItem","position":2,"name":"$2.6M seed round for MIMS, the startup that uses AI to optimize the productivity of biopharmaceutical and agtech companies"}]},{"@type":"WebSite","@id":"https:\/\/www.medteq.ca\/en\/#website","url":"https:\/\/www.medteq.ca\/en\/","name":"MEDTEQ+","description":"Innovation for health","publisher":{"@id":"https:\/\/www.medteq.ca\/en\/#organization"},"alternateName":"MEDTEQ+","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.medteq.ca\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.medteq.ca\/en\/#organization","name":"MEDTEQ+","url":"https:\/\/www.medteq.ca\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.medteq.ca\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.medteq.ca\/wp-content\/uploads\/2024\/11\/medteq-new-logo.png","contentUrl":"https:\/\/www.medteq.ca\/wp-content\/uploads\/2024\/11\/medteq-new-logo.png","width":505,"height":70,"caption":"MEDTEQ+"},"image":{"@id":"https:\/\/www.medteq.ca\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/medteq_ca","https:\/\/www.linkedin.com\/company\/medteq-plus\/"]},{"@type":"Person","@id":"https:\/\/www.medteq.ca\/en\/#\/schema\/person\/deecfd9589f1fadb79527a1f888d8cc5","name":"boreale_user","url":"https:\/\/www.medteq.ca\/en\/author\/boreale\/"}]}},"_links":{"self":[{"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/posts\/3757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/comments?post=3757"}],"version-history":[{"count":0,"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/posts\/3757\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/media?parent=3757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/categories?post=3757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.medteq.ca\/en\/wp-json\/wp\/v2\/tags?post=3757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}